MolecuLightDX Measurement Feature Clinical Validation

Launched by MOLECULIGHT INC. · Nov 8, 2024

Keywords

ClinConnect Summary

This clinical trial, called the MolecuLightDX Measurement Feature Clinical Validation, is studying a device designed to help measure and assess surface wounds in patients with various types of ulcers, such as diabetic foot ulcers and pressure ulcers. The goal is to see how well the MolecuLightDX device works for measuring these wounds, which can help doctors provide better care.

To participate in this study, individuals must be over 22 years old, be willing to follow all study procedures, and have a wound that is larger than 0.5 square centimeters with clearly defined borders. However, people with certain types of wounds, like those that are too large or difficult to measure, may not be eligible. If you join the study, you can expect to have your wound measured using this new device, and your participation will help researchers understand how it can improve wound management in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Willing to consent
• • Willing to comply with all study procedures and availability for the duration of the study
• • Male or female, aged over 22 years old
• • Presented with diabetic foot ulcers, venous, arterial and pressure ulcers
• • Wound size is greater than 0.5 cm2
• • The wound has well-defined wound borders
• Exclusion Criteria:
• • Circumferential wound
• • Wound without clearly defined wound borders
• • Wound located in a difficult to reach/measure location
• • Any contra-indication to routine wound care and/or monitoring
• • Wounds with a length greater than 18.5cm or a width greater than 13.5cm.
• • Tunneled or undermined wounds